Search research articles
Contact Us
Filters
Showing results (661-670 of 706) with videos related to
Page
of 71
Sort By:
Population Health Management
|
December 4, 2024
Identifying Patients with Heart Failure Eligible for Guideline-Directed Medical Therapy
Samantha Subramaniam, Shahzad Hassan, Ozan Unlu, et al.
Obesity (Silver Spring, Md.)
|
December 19, 2024
Contemporary treatment patterns of overweight and obesity: insights from the Mass General Brigham health care system
John W Ostrominski, Kavishwar B Wagholikar, Kelly Olsson, et al.
Journal of the American Heart Association
|
September 2, 2017
Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease
Ralph A H Stewart, Emil Hagström, Claes Held, et al.
JAMA
|
April 5, 2008
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial
Steven E Nissen, Stephen J Nicholls, Kathy Wolski, et al.
Thrombosis Research
|
July 21, 2020
Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis
Antonia Sambola, Pau Rello, Toni Soriano, et al.
Diabetes, Obesity & Metabolism
|
March 26, 2021
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial
Clare Arnott, Jing-Wei Li, Christopher P Cannon, et al.
Journal of the American Heart Association
|
June 23, 2016
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
Lars Wallentin, Claes Held, Paul W Armstrong, et al.
European Heart Journal
|
November 28, 2025
A polygenic risk score for peripheral artery disease and major adverse limb events
Samer Al Said, Siddharth M Patel, Giorgio E M Melloni, et al.
BMJ Open Diabetes Research & Care
|
June 13, 2023
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
David M Charytan, Kenneth W Mahaffey, Meg J Jardine, et al.
Critical Pathways in Cardiology
|
March 15, 2008
Implications of the mechanical (PCI) vs thrombolytic controversy for ST segment elevation myocardial infarction on the organization of emergency medical services: the Boston EMS experience
Peter Moyer, James Feldman, Jon Levine, et al.
Page
of 71
Search research articles
Search
Showing results (661-670 of 706) with videos related to
Sort By:
Page
of 71
Population Health Management
|
December 4, 2024
Identifying Patients with Heart Failure Eligible for Guideline-Directed Medical Therapy
Samantha Subramaniam, Shahzad Hassan, Ozan Unlu, et al.
Obesity (Silver Spring, Md.)
|
December 19, 2024
Contemporary treatment patterns of overweight and obesity: insights from the Mass General Brigham health care system
John W Ostrominski, Kavishwar B Wagholikar, Kelly Olsson, et al.
Journal of the American Heart Association
|
September 2, 2017
Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease
Ralph A H Stewart, Emil Hagström, Claes Held, et al.
JAMA
|
April 5, 2008
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial
Steven E Nissen, Stephen J Nicholls, Kathy Wolski, et al.
Thrombosis Research
|
July 21, 2020
Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis
Antonia Sambola, Pau Rello, Toni Soriano, et al.
Diabetes, Obesity & Metabolism
|
March 26, 2021
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial
Clare Arnott, Jing-Wei Li, Christopher P Cannon, et al.
Journal of the American Heart Association
|
June 23, 2016
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
Lars Wallentin, Claes Held, Paul W Armstrong, et al.
European Heart Journal
|
November 28, 2025
A polygenic risk score for peripheral artery disease and major adverse limb events
Samer Al Said, Siddharth M Patel, Giorgio E M Melloni, et al.
BMJ Open Diabetes Research & Care
|
June 13, 2023
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
David M Charytan, Kenneth W Mahaffey, Meg J Jardine, et al.
Critical Pathways in Cardiology
|
March 15, 2008
Implications of the mechanical (PCI) vs thrombolytic controversy for ST segment elevation myocardial infarction on the organization of emergency medical services: the Boston EMS experience
Peter Moyer, James Feldman, Jon Levine, et al.
Page
of 71